I Adachi
About
In The Last Decade
I Adachi
33 papers receiving 895 citations
Peers
Comparison fields: 5 of 93
- Oncology 592
- Cancer Research 248
- Molecular Biology 190
- Pulmonary and Respiratory Medicine 139
- Public Health, Environmental and Occupational Health 108
Countries citing papers authored by I Adachi
This map shows the geographic impact of I Adachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Adachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Adachi more than expected).
Fields of papers citing papers by I Adachi
This network shows the impact of papers produced by I Adachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Adachi. The network helps show where I Adachi may publish in the future.
Co-authorship network of co-authors of I Adachi
This figure shows the co-authorship network connecting the top 25 collaborators of I Adachi. A scholar is included among the top collaborators of I Adachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Adachi. I Adachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 40 | |
| 3 | 92 | |
| 4 | 31 | |
| 5 | 3 | |
| 6 | 20 | |
| 7 | 11 | |
| 8 | 21 | |
| 9 | 17 | |
| 10 | 17 | |
| 11 | 110 | |
| 12 | 4 | |
| 13 | 78 | |
| 14 | [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive]. | 1 |
| 15 | [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer]. | 6 |
| 16 | [Role of supporting therapy of Juzentaiho-to (JTT) in advanced breast cancer patients]. | 3 |
| 17 | 73 | |
| 18 | [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies]. | 17 |
| 19 | [Hypercalcemia in malignancy]. | 1 |
| 20 | [Human calcitonin in plasma and tissues. I. Human calcitonin in plasma (author's transl)]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.